Vanguard Group’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,031
| Closed | -$63K | – | 4530 |
|
|
2023
Q4 | $63K | Sell |
14,031
-6,990
| -33% | -$24.5K | ﹤0.01% | 4353 |
|
|
2023
Q3 | $127K | Sell |
21,021
-149
| -0.7% | -$1.53K | ﹤0.01% | 4318 |
|
|
2023
Q2 | $259K | Hold |
21,170
| – | – | ﹤0.01% | 4263 |
|
|
2023
Q1 | $303K | Hold |
21,170
| – | – | ﹤0.01% | 4247 |
|
|
2022
Q4 | $317K | Buy |
21,170
+36
| +0.2% | +$1.04K | ﹤0.01% | 4210 |
|
|
2022
Q3 | $820K | Sell |
21,134
-593
| -3% | -$34K | ﹤0.01% | 4061 |
|
|
2022
Q2 | $1.66M | Buy |
21,727
+11,071
| +104% | +$971K | ﹤0.01% | 3883 |
|
|
2022
Q1 | $517K | Sell |
10,656
-3,876
| -27% | -$233K | ﹤0.01% | 4390 |
|
|
2021
Q4 | $1.02M | Sell |
14,532
-2,900
| -17% | -$312K | ﹤0.01% | 4260 |
|
|
2021
Q3 | $2.54M | Buy |
17,432
+240
| +1% | +$72.8K | ﹤0.01% | 3987 |
|
|
2021
Q2 | $10.5M | Buy |
17,192
+2,510
| +17% | +$1.64M | ﹤0.01% | 3170 |
|
|
2021
Q1 | $10.3M | Buy |
+14,682
| New | +$10.6M | ﹤0.01% | 3133 |
|
|
2020
Q4 | – | Sell |
-115
| Closed | -$95K | – | 4224 |
|
|
2020
Q3 | $95K | Hold |
115
| – | – | ﹤0.01% | 4017 |
|
|
2020
Q2 | $61K | Buy |
115
+33
| +40% | +$19.3K | ﹤0.01% | 4021 |
|
|
2020
Q1 | $45K | Hold |
82
| – | – | ﹤0.01% | 4005 |
|
|
2019
Q4 | $59K | Hold |
82
| – | – | ﹤0.01% | 4041 |
|
|
2019
Q3 | $71K | Hold |
82
| – | – | ﹤0.01% | 4059 |
|
|
2019
Q2 | $74K | Hold |
82
| – | – | ﹤0.01% | 4076 |
|
|
2019
Q1 | $78K | Buy |
82
+1
| +1% | +$954 | ﹤0.01% | 4028 |
|
|
2018
Q4 | $69K | Buy |
81
+44
| +119% | +$33.4K | ﹤0.01% | 4041 |
|
|
2018
Q3 | $27K | Hold |
37
| – | – | ﹤0.01% | 4148 |
|
|
2018
Q2 | $33K | Hold |
37
| – | – | ﹤0.01% | 4112 |
|
|
2018
Q1 | $28K | Hold |
37
| – | – | ﹤0.01% | 4083 |
|
|
2017
Q4 | $30K | Buy |
37
+5
| +16% | +$4.05K | ﹤0.01% | 4044 |
|
|
2017
Q3 | $26K | Hold |
32
| – | – | ﹤0.01% | 4053 |
|
|
2017
Q2 | $35K | Buy |
32
+5
| +19% | +$6.65K | ﹤0.01% | 4043 |
|
|
2017
Q1 | $47K | Buy |
+27
| New | +$49.7K | ﹤0.01% | 4028 |
|
Vanguard Group's MDVL Position: Q1 2024 in Review
Vanguard Group sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 14,031 shares — an estimated $63K sold.
Vanguard Group first reported a position in MDVL in Q1 2017 and held it in 27 quarters. The position peaked at $10.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.
- Vanguard Group reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Vanguard Group sold 14,031 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $63K.
- Vanguard Group first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2017 and held it in 27 quarters.
- Vanguard Group's MedAvail Holdings, Inc. Common Stock position peaked at $10.5M in Q2 2021.
- 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.
Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.